Literature DB >> 25801282

Perinatal Gjb2 gene transfer rescues hearing in a mouse model of hereditary deafness.

Takashi Iizuka1, Kazusaku Kamiya1, Satoru Gotoh2, Yoshinobu Sugitani2, Masaaki Suzuki3, Tetsuo Noda4, Osamu Minowa4, Katsuhisa Ikeda5.   

Abstract

Hearing loss is the most widespread sensory disorder, with an incidence of congenital genetic deafness of 1 in 1600 children. For many ethnic populations, the most prevalent form of genetic deafness is caused by recessive mutations in the gene gap junction protein, beta 2, 26 kDa (GJB2), which is also known as connexin 26 (Cx26). Despite this knowledge, existing treatment strategies do not completely recover speech perception. Here we used a gene delivery system to rescue hearing in a mouse model of Gjb2 deletion. Mice lacking Cx26 are characterized by profound deafness from birth and improper development of cochlear cells. Cochlear delivery of Gjb2 using an adeno-associated virus significantly improved the auditory responses and development of the cochlear structure. Using gene replacement to restore hearing in a new mouse model of Gjb2-related deafness may lead to the development of therapies for human hereditary deafness.
© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25801282     DOI: 10.1093/hmg/ddv109

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  30 in total

Review 1.  Inner ear manifestations in CHARGE: Abnormalities, treatments, animal models, and progress toward treatments in auditory and vestibular structures.

Authors:  Daniel I Choo; Kareem O Tawfik; Donna M Martin; Yehoash Raphael
Journal:  Am J Med Genet C Semin Med Genet       Date:  2017-10-30       Impact factor: 3.908

Review 2.  Gene therapy for hearing loss.

Authors:  Ryotaro Omichi; Seiji B Shibata; Cynthia C Morton; Richard J H Smith
Journal:  Hum Mol Genet       Date:  2019-10-01       Impact factor: 6.150

Review 3.  Emerging Gene Therapies for Genetic Hearing Loss.

Authors:  Hena Ahmed; Olga Shubina-Oleinik; Jeffrey R Holt
Journal:  J Assoc Res Otolaryngol       Date:  2017-08-16

Review 4.  Cochlear hair cell regeneration after noise-induced hearing loss: Does regeneration follow development?

Authors:  Fei Zheng; Jian Zuo
Journal:  Hear Res       Date:  2016-12-26       Impact factor: 3.208

5.  Targeted Allele Suppression Prevents Progressive Hearing Loss in the Mature Murine Model of Human TMC1 Deafness.

Authors:  Hidekane Yoshimura; Seiji B Shibata; Paul T Ranum; Hideaki Moteki; Richard J H Smith
Journal:  Mol Ther       Date:  2019-01-07       Impact factor: 11.454

Review 6.  Advances in genome editing for genetic hearing loss.

Authors:  Ning Ding; Sangsin Lee; Matan Lieber-Kotz; Jie Yang; Xue Gao
Journal:  Adv Drug Deliv Rev       Date:  2020-05-07       Impact factor: 15.470

Review 7.  Delivering AAV to the Central Nervous and Sensory Systems.

Authors:  Cole W Peters; Casey A Maguire; Killian S Hanlon
Journal:  Trends Pharmacol Sci       Date:  2021-04-13       Impact factor: 17.638

Review 8.  Genetic Therapies for Hearing Loss: Accomplishments and Remaining Challenges.

Authors:  Shahar Taiber; Karen B Avraham
Journal:  Neurosci Lett       Date:  2019-10-03       Impact factor: 3.046

9.  Deformation of the Outer Hair Cells and the Accumulation of Caveolin-2 in Connexin 26 Deficient Mice.

Authors:  Takashi Anzai; Ichiro Fukunaga; Kaori Hatakeyama; Ayumi Fujimoto; Kazuma Kobayashi; Atena Nishikawa; Toru Aoki; Tetsuo Noda; Osamu Minowa; Katsuhisa Ikeda; Kazusaku Kamiya
Journal:  PLoS One       Date:  2015-10-22       Impact factor: 3.240

Review 10.  Practical aspects of inner ear gene delivery for research and clinical applications.

Authors:  Sungsu Lee; Anna Dondzillo; Samuel P Gubbels; Yehoash Raphael
Journal:  Hear Res       Date:  2020-03-06       Impact factor: 3.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.